Dr. Blumberg is Professor of Medicine, Harvard Medical School, Chief of Gastroenterology, Brigham and Women’s Hospital, co-Director of the Harvard Digestive Diseases Center and past-Director of the Brigham Research Institute. He has directed a National Institutes of Health funded laboratory since 1989 which has a particular emphasis on the immunologic functions of the intestinal epithelium; a field that his laboratory has pioneered through the study of non classical MHC class I molecules and more recently the unfolded protein response and Paneth cell function and is a leading authority on carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) and the neonatal crystallizable fragment receptor (FcRn) function. Dr. Blumberg has been the recipient of the an NIH Method to Extend Research in Time (M.E.R.I.T) Award (2005), the William Beaumont Prize (2009), the CCFA Scientific Achievement Award in Inflammatory Bowel Disease Basic Research (2012), a Lifetime Scientific Achievement Award from the Society for Mucosal Immunology (2015), the Lloyd Mayer Award in Mucosal Immunology and is an elected member of the Norwegian Academy of Sciences.